Moreover, the expression of ABCA1, ABCA5, SCARB1, ALB, APOA1, and LCAT, all belonging to the major participants in reverse cholesterol transport, was down-regulated, evidencing RCT deficiency at CAD. This evidence concerns the gene ABCA5 and coronary artery disorder.